University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
J Autoimmun. 2020 Jun;110:102374. doi: 10.1016/j.jaut.2019.102374. Epub 2019 Dec 4.
While systemic lupus erythematosus (SLE) is an autoantibody and immune complex disease by nature, most of its organ manifestations are in fact inflammatory. SLE activity scores thus heavily rely on assessing inflammation in the various organs. This focus on clinical items demonstrates that routine laboratory markers of inflammation are still limited in their impact. The erythrocyte sedimentation rate (ESR) is used, but represents a rather crude overall measure. Anemia and diminished serum albumin play a role in estimating inflammatory activity, but both are reflecting more than one mechanism, and the association with inflammation is complex. C-reactive protein (CRP) is a better marker for infections than for SLE activity, where there is only a limited association, and procalcitonin (PCT) is also mainly used for detecting severe bacterial infection. Of the cytokines directly induced by immune complexes, type I interferons, interleukin-18 (IL-18) and tumor necrosis factor (TNF) are correlated with inflammatory disease activity. Still, precise and timely measurement is an issue, which is why they are not currently used for routine purposes. While somewhat more robust in the assays, IL-18 binding protein (IL-18BP) and soluble TNF-receptor 2 (TNF-R2), which are related to the respective cytokines, have not yet made it into clinical routine. The same is true for several chemokines that are increased with activity and relatively easy to measure, but still experimental parameters. In the urine, proteinuria leads and is essential for assessing kidney involvement, but may also result from damage. Similar to the situation in serum and plasma, several cytokines and chemokines perform reasonably well in scientific studies, but are not routine parameters. Cellular elements in the urine are more difficult to assess in the routine laboratory, where sufficient routine is not always available. Therefore, the analysis of urinary T cells may have potential for better monitoring renal inflammation.
虽然系统性红斑狼疮 (SLE) 本质上是一种自身抗体和免疫复合物疾病,但它的大多数器官表现实际上都是炎症。因此,SLE 活动评分严重依赖于评估各种器官的炎症。这种对临床项目的关注表明,常规实验室炎症标志物在其影响方面仍然有限。红细胞沉降率 (ESR) 被使用,但它只是一种相当粗糙的整体衡量标准。贫血和血清白蛋白减少在估计炎症活动中起作用,但它们都反映了不止一种机制,并且与炎症的关联很复杂。C 反应蛋白 (CRP) 是感染的更好标志物,而不是 SLE 活动的标志物,CRP 与 SLE 活动的关联有限,降钙素原 (PCT) 也主要用于检测严重细菌感染。在免疫复合物直接诱导的细胞因子中,I 型干扰素、白细胞介素-18 (IL-18) 和肿瘤坏死因子 (TNF) 与炎症性疾病活动相关。然而,精确和及时的测量仍然是一个问题,这就是为什么它们目前不用于常规用途。虽然在检测中更可靠,但与各自细胞因子相关的 IL-18 结合蛋白 (IL-18BP) 和可溶性 TNF 受体 2 (TNF-R2) 尚未进入临床常规。几种趋化因子也是如此,它们随着活动的增加而增加,并且相对容易测量,但仍然是实验参数。在尿液中,蛋白尿是评估肾脏受累的先导和必要条件,但也可能是由损伤引起的。与血清和血浆中的情况类似,几种细胞因子和趋化因子在科学研究中表现相当不错,但不是常规参数。尿液中的细胞成分在常规实验室中更难评估,常规实验室中并非总是有足够的常规方法。因此,尿液 T 细胞分析可能具有更好监测肾脏炎症的潜力。